Pharma & Healthcare
Global Human Vaccination Market Research Report 2025
- Mar 11, 25
- ID: 31733
- Pages: 98
- Figures: 96
- Views: 8
The global market for Human Vaccination was valued at US$ 59960 million in the year 2024 and is projected to reach a revised size of US$ 76800 million by 2031, growing at a CAGR of 3.7% during the forecast period.
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body"s immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Human Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Vaccination.
The Human Vaccination market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Vaccination market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Vaccination companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCAMS
Convac
NCPC
Bio Kangtai
Dynavax
Hissen
KM Biologics
LG Life Sciences
Serum Institute
Pfizer
Segment by Type
Inactivated Vaccine
Live-attenuated Vaccine
mRNA Vaccine
Conjugate Vaccine
Other
Segment by Application
Government Institution
Private Sector
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Vaccination company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body"s immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Human Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Vaccination.
The Human Vaccination market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Vaccination market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Vaccination companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCAMS
Convac
NCPC
Bio Kangtai
Dynavax
Hissen
KM Biologics
LG Life Sciences
Serum Institute
Pfizer
Segment by Type
Inactivated Vaccine
Live-attenuated Vaccine
mRNA Vaccine
Conjugate Vaccine
Other
Segment by Application
Government Institution
Private Sector
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Vaccination company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Vaccination Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Inactivated Vaccine
1.2.3 Live-attenuated Vaccine
1.2.4 mRNA Vaccine
1.2.5 Conjugate Vaccine
1.2.6 Other
1.3 Market by Application
1.3.1 Global Human Vaccination Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Vaccination Market Perspective (2020-2031)
2.2 Global Human Vaccination Growth Trends by Region
2.2.1 Global Human Vaccination Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Human Vaccination Historic Market Size by Region (2020-2025)
2.2.3 Human Vaccination Forecasted Market Size by Region (2026-2031)
2.3 Human Vaccination Market Dynamics
2.3.1 Human Vaccination Industry Trends
2.3.2 Human Vaccination Market Drivers
2.3.3 Human Vaccination Market Challenges
2.3.4 Human Vaccination Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Vaccination Players by Revenue
3.1.1 Global Top Human Vaccination Players by Revenue (2020-2025)
3.1.2 Global Human Vaccination Revenue Market Share by Players (2020-2025)
3.2 Global Human Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Human Vaccination Revenue
3.4 Global Human Vaccination Market Concentration Ratio
3.4.1 Global Human Vaccination Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Vaccination Revenue in 2024
3.5 Global Key Players of Human Vaccination Head office and Area Served
3.6 Global Key Players of Human Vaccination, Product and Application
3.7 Global Key Players of Human Vaccination, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Vaccination Breakdown Data by Type
4.1 Global Human Vaccination Historic Market Size by Type (2020-2025)
4.2 Global Human Vaccination Forecasted Market Size by Type (2026-2031)
5 Human Vaccination Breakdown Data by Application
5.1 Global Human Vaccination Historic Market Size by Application (2020-2025)
5.2 Global Human Vaccination Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Human Vaccination Market Size (2020-2031)
6.2 North America Human Vaccination Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Human Vaccination Market Size by Country (2020-2025)
6.4 North America Human Vaccination Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Vaccination Market Size (2020-2031)
7.2 Europe Human Vaccination Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Human Vaccination Market Size by Country (2020-2025)
7.4 Europe Human Vaccination Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Vaccination Market Size (2020-2031)
8.2 Asia-Pacific Human Vaccination Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Human Vaccination Market Size by Region (2020-2025)
8.4 Asia-Pacific Human Vaccination Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Vaccination Market Size (2020-2031)
9.2 Latin America Human Vaccination Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Human Vaccination Market Size by Country (2020-2025)
9.4 Latin America Human Vaccination Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Vaccination Market Size (2020-2031)
10.2 Middle East & Africa Human Vaccination Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Human Vaccination Market Size by Country (2020-2025)
10.4 Middle East & Africa Human Vaccination Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Human Vaccination Introduction
11.1.4 GSK Revenue in Human Vaccination Business (2020-2025)
11.1.5 GSK Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Human Vaccination Introduction
11.2.4 Merck Revenue in Human Vaccination Business (2020-2025)
11.2.5 Merck Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Human Vaccination Introduction
11.3.4 Sanofi Revenue in Human Vaccination Business (2020-2025)
11.3.5 Sanofi Recent Development
11.4 Sinovac
11.4.1 Sinovac Company Details
11.4.2 Sinovac Business Overview
11.4.3 Sinovac Human Vaccination Introduction
11.4.4 Sinovac Revenue in Human Vaccination Business (2020-2025)
11.4.5 Sinovac Recent Development
11.5 Zhejiang Pukang
11.5.1 Zhejiang Pukang Company Details
11.5.2 Zhejiang Pukang Business Overview
11.5.3 Zhejiang Pukang Human Vaccination Introduction
11.5.4 Zhejiang Pukang Revenue in Human Vaccination Business (2020-2025)
11.5.5 Zhejiang Pukang Recent Development
11.6 Changchun Institute of Biological
11.6.1 Changchun Institute of Biological Company Details
11.6.2 Changchun Institute of Biological Business Overview
11.6.3 Changchun Institute of Biological Human Vaccination Introduction
11.6.4 Changchun Institute of Biological Revenue in Human Vaccination Business (2020-2025)
11.6.5 Changchun Institute of Biological Recent Development
11.7 KM Biologics
11.7.1 KM Biologics Company Details
11.7.2 KM Biologics Business Overview
11.7.3 KM Biologics Human Vaccination Introduction
11.7.4 KM Biologics Revenue in Human Vaccination Business (2020-2025)
11.7.5 KM Biologics Recent Development
11.8 IMBCAMS
11.8.1 IMBCAMS Company Details
11.8.2 IMBCAMS Business Overview
11.8.3 IMBCAMS Human Vaccination Introduction
11.8.4 IMBCAMS Revenue in Human Vaccination Business (2020-2025)
11.8.5 IMBCAMS Recent Development
11.9 Convac
11.9.1 Convac Company Details
11.9.2 Convac Business Overview
11.9.3 Convac Human Vaccination Introduction
11.9.4 Convac Revenue in Human Vaccination Business (2020-2025)
11.9.5 Convac Recent Development
11.10 NCPC
11.10.1 NCPC Company Details
11.10.2 NCPC Business Overview
11.10.3 NCPC Human Vaccination Introduction
11.10.4 NCPC Revenue in Human Vaccination Business (2020-2025)
11.10.5 NCPC Recent Development
11.11 Bio Kangtai
11.11.1 Bio Kangtai Company Details
11.11.2 Bio Kangtai Business Overview
11.11.3 Bio Kangtai Human Vaccination Introduction
11.11.4 Bio Kangtai Revenue in Human Vaccination Business (2020-2025)
11.11.5 Bio Kangtai Recent Development
11.12 Dynavax
11.12.1 Dynavax Company Details
11.12.2 Dynavax Business Overview
11.12.3 Dynavax Human Vaccination Introduction
11.12.4 Dynavax Revenue in Human Vaccination Business (2020-2025)
11.12.5 Dynavax Recent Development
11.13 Hissen
11.13.1 Hissen Company Details
11.13.2 Hissen Business Overview
11.13.3 Hissen Human Vaccination Introduction
11.13.4 Hissen Revenue in Human Vaccination Business (2020-2025)
11.13.5 Hissen Recent Development
11.14 KM Biologics
11.14.1 KM Biologics Company Details
11.14.2 KM Biologics Business Overview
11.14.3 KM Biologics Human Vaccination Introduction
11.14.4 KM Biologics Revenue in Human Vaccination Business (2020-2025)
11.14.5 KM Biologics Recent Development
11.15 LG Life Sciences
11.15.1 LG Life Sciences Company Details
11.15.2 LG Life Sciences Business Overview
11.15.3 LG Life Sciences Human Vaccination Introduction
11.15.4 LG Life Sciences Revenue in Human Vaccination Business (2020-2025)
11.15.5 LG Life Sciences Recent Development
11.16 Serum Institute
11.16.1 Serum Institute Company Details
11.16.2 Serum Institute Business Overview
11.16.3 Serum Institute Human Vaccination Introduction
11.16.4 Serum Institute Revenue in Human Vaccination Business (2020-2025)
11.16.5 Serum Institute Recent Development
11.17 Pfizer
11.17.1 Pfizer Company Details
11.17.2 Pfizer Business Overview
11.17.3 Pfizer Human Vaccination Introduction
11.17.4 Pfizer Revenue in Human Vaccination Business (2020-2025)
11.17.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Vaccination Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Inactivated Vaccine
1.2.3 Live-attenuated Vaccine
1.2.4 mRNA Vaccine
1.2.5 Conjugate Vaccine
1.2.6 Other
1.3 Market by Application
1.3.1 Global Human Vaccination Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Vaccination Market Perspective (2020-2031)
2.2 Global Human Vaccination Growth Trends by Region
2.2.1 Global Human Vaccination Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Human Vaccination Historic Market Size by Region (2020-2025)
2.2.3 Human Vaccination Forecasted Market Size by Region (2026-2031)
2.3 Human Vaccination Market Dynamics
2.3.1 Human Vaccination Industry Trends
2.3.2 Human Vaccination Market Drivers
2.3.3 Human Vaccination Market Challenges
2.3.4 Human Vaccination Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Vaccination Players by Revenue
3.1.1 Global Top Human Vaccination Players by Revenue (2020-2025)
3.1.2 Global Human Vaccination Revenue Market Share by Players (2020-2025)
3.2 Global Human Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Human Vaccination Revenue
3.4 Global Human Vaccination Market Concentration Ratio
3.4.1 Global Human Vaccination Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Vaccination Revenue in 2024
3.5 Global Key Players of Human Vaccination Head office and Area Served
3.6 Global Key Players of Human Vaccination, Product and Application
3.7 Global Key Players of Human Vaccination, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Vaccination Breakdown Data by Type
4.1 Global Human Vaccination Historic Market Size by Type (2020-2025)
4.2 Global Human Vaccination Forecasted Market Size by Type (2026-2031)
5 Human Vaccination Breakdown Data by Application
5.1 Global Human Vaccination Historic Market Size by Application (2020-2025)
5.2 Global Human Vaccination Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Human Vaccination Market Size (2020-2031)
6.2 North America Human Vaccination Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Human Vaccination Market Size by Country (2020-2025)
6.4 North America Human Vaccination Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Vaccination Market Size (2020-2031)
7.2 Europe Human Vaccination Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Human Vaccination Market Size by Country (2020-2025)
7.4 Europe Human Vaccination Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Vaccination Market Size (2020-2031)
8.2 Asia-Pacific Human Vaccination Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Human Vaccination Market Size by Region (2020-2025)
8.4 Asia-Pacific Human Vaccination Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Vaccination Market Size (2020-2031)
9.2 Latin America Human Vaccination Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Human Vaccination Market Size by Country (2020-2025)
9.4 Latin America Human Vaccination Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Vaccination Market Size (2020-2031)
10.2 Middle East & Africa Human Vaccination Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Human Vaccination Market Size by Country (2020-2025)
10.4 Middle East & Africa Human Vaccination Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Human Vaccination Introduction
11.1.4 GSK Revenue in Human Vaccination Business (2020-2025)
11.1.5 GSK Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Human Vaccination Introduction
11.2.4 Merck Revenue in Human Vaccination Business (2020-2025)
11.2.5 Merck Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Human Vaccination Introduction
11.3.4 Sanofi Revenue in Human Vaccination Business (2020-2025)
11.3.5 Sanofi Recent Development
11.4 Sinovac
11.4.1 Sinovac Company Details
11.4.2 Sinovac Business Overview
11.4.3 Sinovac Human Vaccination Introduction
11.4.4 Sinovac Revenue in Human Vaccination Business (2020-2025)
11.4.5 Sinovac Recent Development
11.5 Zhejiang Pukang
11.5.1 Zhejiang Pukang Company Details
11.5.2 Zhejiang Pukang Business Overview
11.5.3 Zhejiang Pukang Human Vaccination Introduction
11.5.4 Zhejiang Pukang Revenue in Human Vaccination Business (2020-2025)
11.5.5 Zhejiang Pukang Recent Development
11.6 Changchun Institute of Biological
11.6.1 Changchun Institute of Biological Company Details
11.6.2 Changchun Institute of Biological Business Overview
11.6.3 Changchun Institute of Biological Human Vaccination Introduction
11.6.4 Changchun Institute of Biological Revenue in Human Vaccination Business (2020-2025)
11.6.5 Changchun Institute of Biological Recent Development
11.7 KM Biologics
11.7.1 KM Biologics Company Details
11.7.2 KM Biologics Business Overview
11.7.3 KM Biologics Human Vaccination Introduction
11.7.4 KM Biologics Revenue in Human Vaccination Business (2020-2025)
11.7.5 KM Biologics Recent Development
11.8 IMBCAMS
11.8.1 IMBCAMS Company Details
11.8.2 IMBCAMS Business Overview
11.8.3 IMBCAMS Human Vaccination Introduction
11.8.4 IMBCAMS Revenue in Human Vaccination Business (2020-2025)
11.8.5 IMBCAMS Recent Development
11.9 Convac
11.9.1 Convac Company Details
11.9.2 Convac Business Overview
11.9.3 Convac Human Vaccination Introduction
11.9.4 Convac Revenue in Human Vaccination Business (2020-2025)
11.9.5 Convac Recent Development
11.10 NCPC
11.10.1 NCPC Company Details
11.10.2 NCPC Business Overview
11.10.3 NCPC Human Vaccination Introduction
11.10.4 NCPC Revenue in Human Vaccination Business (2020-2025)
11.10.5 NCPC Recent Development
11.11 Bio Kangtai
11.11.1 Bio Kangtai Company Details
11.11.2 Bio Kangtai Business Overview
11.11.3 Bio Kangtai Human Vaccination Introduction
11.11.4 Bio Kangtai Revenue in Human Vaccination Business (2020-2025)
11.11.5 Bio Kangtai Recent Development
11.12 Dynavax
11.12.1 Dynavax Company Details
11.12.2 Dynavax Business Overview
11.12.3 Dynavax Human Vaccination Introduction
11.12.4 Dynavax Revenue in Human Vaccination Business (2020-2025)
11.12.5 Dynavax Recent Development
11.13 Hissen
11.13.1 Hissen Company Details
11.13.2 Hissen Business Overview
11.13.3 Hissen Human Vaccination Introduction
11.13.4 Hissen Revenue in Human Vaccination Business (2020-2025)
11.13.5 Hissen Recent Development
11.14 KM Biologics
11.14.1 KM Biologics Company Details
11.14.2 KM Biologics Business Overview
11.14.3 KM Biologics Human Vaccination Introduction
11.14.4 KM Biologics Revenue in Human Vaccination Business (2020-2025)
11.14.5 KM Biologics Recent Development
11.15 LG Life Sciences
11.15.1 LG Life Sciences Company Details
11.15.2 LG Life Sciences Business Overview
11.15.3 LG Life Sciences Human Vaccination Introduction
11.15.4 LG Life Sciences Revenue in Human Vaccination Business (2020-2025)
11.15.5 LG Life Sciences Recent Development
11.16 Serum Institute
11.16.1 Serum Institute Company Details
11.16.2 Serum Institute Business Overview
11.16.3 Serum Institute Human Vaccination Introduction
11.16.4 Serum Institute Revenue in Human Vaccination Business (2020-2025)
11.16.5 Serum Institute Recent Development
11.17 Pfizer
11.17.1 Pfizer Company Details
11.17.2 Pfizer Business Overview
11.17.3 Pfizer Human Vaccination Introduction
11.17.4 Pfizer Revenue in Human Vaccination Business (2020-2025)
11.17.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Human Vaccination Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Inactivated Vaccine
Table 3. Key Players of Live-attenuated Vaccine
Table 4. Key Players of mRNA Vaccine
Table 5. Key Players of Conjugate Vaccine
Table 6. Key Players of Other
Table 7. Global Human Vaccination Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Human Vaccination Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Human Vaccination Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Human Vaccination Market Share by Region (2020-2025)
Table 11. Global Human Vaccination Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Human Vaccination Market Share by Region (2026-2031)
Table 13. Human Vaccination Market Trends
Table 14. Human Vaccination Market Drivers
Table 15. Human Vaccination Market Challenges
Table 16. Human Vaccination Market Restraints
Table 17. Global Human Vaccination Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Human Vaccination Market Share by Players (2020-2025)
Table 19. Global Top Human Vaccination Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Vaccination as of 2024)
Table 20. Ranking of Global Top Human Vaccination Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Human Vaccination Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Human Vaccination, Headquarters and Area Served
Table 23. Global Key Players of Human Vaccination, Product and Application
Table 24. Global Key Players of Human Vaccination, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Human Vaccination Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Human Vaccination Revenue Market Share by Type (2020-2025)
Table 28. Global Human Vaccination Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Human Vaccination Revenue Market Share by Type (2026-2031)
Table 30. Global Human Vaccination Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Human Vaccination Revenue Market Share by Application (2020-2025)
Table 32. Global Human Vaccination Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Human Vaccination Revenue Market Share by Application (2026-2031)
Table 34. North America Human Vaccination Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Human Vaccination Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Human Vaccination Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Human Vaccination Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Human Vaccination Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Human Vaccination Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Human Vaccination Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Human Vaccination Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Human Vaccination Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Human Vaccination Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Human Vaccination Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Human Vaccination Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Human Vaccination Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Human Vaccination Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Human Vaccination Market Size by Country (2026-2031) & (US$ Million)
Table 49. GSK Company Details
Table 50. GSK Business Overview
Table 51. GSK Human Vaccination Product
Table 52. GSK Revenue in Human Vaccination Business (2020-2025) & (US$ Million)
Table 53. GSK Recent Development
Table 54. Merck Company Details
Table 55. Merck Business Overview
Table 56. Merck Human Vaccination Product
Table 57. Merck Revenue in Human Vaccination Business (2020-2025) & (US$ Million)
Table 58. Merck Recent Development
Table 59. Sanofi Company Details
Table 60. Sanofi Business Overview
Table 61. Sanofi Human Vaccination Product
Table 62. Sanofi Revenue in Human Vaccination Business (2020-2025) & (US$ Million)
Table 63. Sanofi Recent Development
Table 64. Sinovac Company Details
Table 65. Sinovac Business Overview
Table 66. Sinovac Human Vaccination Product
Table 67. Sinovac Revenue in Human Vaccination Business (2020-2025) & (US$ Million)
Table 68. Sinovac Recent Development
Table 69. Zhejiang Pukang Company Details
Table 70. Zhejiang Pukang Business Overview
Table 71. Zhejiang Pukang Human Vaccination Product
Table 72. Zhejiang Pukang Revenue in Human Vaccination Business (2020-2025) & (US$ Million)
Table 73. Zhejiang Pukang Recent Development
Table 74. Changchun Institute of Biological Company Details
Table 75. Changchun Institute of Biological Business Overview
Table 76. Changchun Institute of Biological Human Vaccination Product
Table 77. Changchun Institute of Biological Revenue in Human Vaccination Business (2020-2025) & (US$ Million)
Table 78. Changchun Institute of Biological Recent Development
Table 79. KM Biologics Company Details
Table 80. KM Biologics Business Overview
Table 81. KM Biologics Human Vaccination Product
Table 82. KM Biologics Revenue in Human Vaccination Business (2020-2025) & (US$ Million)
Table 83. KM Biologics Recent Development
Table 84. IMBCAMS Company Details
Table 85. IMBCAMS Business Overview
Table 86. IMBCAMS Human Vaccination Product
Table 87. IMBCAMS Revenue in Human Vaccination Business (2020-2025) & (US$ Million)
Table 88. IMBCAMS Recent Development
Table 89. Convac Company Details
Table 90. Convac Business Overview
Table 91. Convac Human Vaccination Product
Table 92. Convac Revenue in Human Vaccination Business (2020-2025) & (US$ Million)
Table 93. Convac Recent Development
Table 94. NCPC Company Details
Table 95. NCPC Business Overview
Table 96. NCPC Human Vaccination Product
Table 97. NCPC Revenue in Human Vaccination Business (2020-2025) & (US$ Million)
Table 98. NCPC Recent Development
Table 99. Bio Kangtai Company Details
Table 100. Bio Kangtai Business Overview
Table 101. Bio Kangtai Human Vaccination Product
Table 102. Bio Kangtai Revenue in Human Vaccination Business (2020-2025) & (US$ Million)
Table 103. Bio Kangtai Recent Development
Table 104. Dynavax Company Details
Table 105. Dynavax Business Overview
Table 106. Dynavax Human Vaccination Product
Table 107. Dynavax Revenue in Human Vaccination Business (2020-2025) & (US$ Million)
Table 108. Dynavax Recent Development
Table 109. Hissen Company Details
Table 110. Hissen Business Overview
Table 111. Hissen Human Vaccination Product
Table 112. Hissen Revenue in Human Vaccination Business (2020-2025) & (US$ Million)
Table 113. Hissen Recent Development
Table 114. KM Biologics Company Details
Table 115. KM Biologics Business Overview
Table 116. KM Biologics Human Vaccination Product
Table 117. KM Biologics Revenue in Human Vaccination Business (2020-2025) & (US$ Million)
Table 118. KM Biologics Recent Development
Table 119. LG Life Sciences Company Details
Table 120. LG Life Sciences Business Overview
Table 121. LG Life Sciences Human Vaccination Product
Table 122. LG Life Sciences Revenue in Human Vaccination Business (2020-2025) & (US$ Million)
Table 123. LG Life Sciences Recent Development
Table 124. Serum Institute Company Details
Table 125. Serum Institute Business Overview
Table 126. Serum Institute Human Vaccination Product
Table 127. Serum Institute Revenue in Human Vaccination Business (2020-2025) & (US$ Million)
Table 128. Serum Institute Recent Development
Table 129. Pfizer Company Details
Table 130. Pfizer Business Overview
Table 131. Pfizer Human Vaccination Product
Table 132. Pfizer Revenue in Human Vaccination Business (2020-2025) & (US$ Million)
Table 133. Pfizer Recent Development
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
Table 137. Authors List of This Report
List of Figures
Figure 1. Human Vaccination Picture
Figure 2. Global Human Vaccination Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Human Vaccination Market Share by Type: 2024 VS 2031
Figure 4. Inactivated Vaccine Features
Figure 5. Live-attenuated Vaccine Features
Figure 6. mRNA Vaccine Features
Figure 7. Conjugate Vaccine Features
Figure 8. Other Features
Figure 9. Global Human Vaccination Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Human Vaccination Market Share by Application: 2024 VS 2031
Figure 11. Government Institution Case Studies
Figure 12. Private Sector Case Studies
Figure 13. Other Case Studies
Figure 14. Human Vaccination Report Years Considered
Figure 15. Global Human Vaccination Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Human Vaccination Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Human Vaccination Market Share by Region: 2024 VS 2031
Figure 18. Global Human Vaccination Market Share by Players in 2024
Figure 19. Global Top Human Vaccination Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Vaccination as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Human Vaccination Revenue in 2024
Figure 21. North America Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Human Vaccination Market Share by Country (2020-2031)
Figure 23. United States Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Human Vaccination Market Share by Country (2020-2031)
Figure 27. Germany Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Human Vaccination Market Share by Region (2020-2031)
Figure 35. China Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Human Vaccination Market Share by Country (2020-2031)
Figure 43. Mexico Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Human Vaccination Market Share by Country (2020-2031)
Figure 47. Turkey Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. GSK Revenue Growth Rate in Human Vaccination Business (2020-2025)
Figure 51. Merck Revenue Growth Rate in Human Vaccination Business (2020-2025)
Figure 52. Sanofi Revenue Growth Rate in Human Vaccination Business (2020-2025)
Figure 53. Sinovac Revenue Growth Rate in Human Vaccination Business (2020-2025)
Figure 54. Zhejiang Pukang Revenue Growth Rate in Human Vaccination Business (2020-2025)
Figure 55. Changchun Institute of Biological Revenue Growth Rate in Human Vaccination Business (2020-2025)
Figure 56. KM Biologics Revenue Growth Rate in Human Vaccination Business (2020-2025)
Figure 57. IMBCAMS Revenue Growth Rate in Human Vaccination Business (2020-2025)
Figure 58. Convac Revenue Growth Rate in Human Vaccination Business (2020-2025)
Figure 59. NCPC Revenue Growth Rate in Human Vaccination Business (2020-2025)
Figure 60. Bio Kangtai Revenue Growth Rate in Human Vaccination Business (2020-2025)
Figure 61. Dynavax Revenue Growth Rate in Human Vaccination Business (2020-2025)
Figure 62. Hissen Revenue Growth Rate in Human Vaccination Business (2020-2025)
Figure 63. KM Biologics Revenue Growth Rate in Human Vaccination Business (2020-2025)
Figure 64. LG Life Sciences Revenue Growth Rate in Human Vaccination Business (2020-2025)
Figure 65. Serum Institute Revenue Growth Rate in Human Vaccination Business (2020-2025)
Figure 66. Pfizer Revenue Growth Rate in Human Vaccination Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Table 1. Global Human Vaccination Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Inactivated Vaccine
Table 3. Key Players of Live-attenuated Vaccine
Table 4. Key Players of mRNA Vaccine
Table 5. Key Players of Conjugate Vaccine
Table 6. Key Players of Other
Table 7. Global Human Vaccination Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Human Vaccination Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Human Vaccination Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Human Vaccination Market Share by Region (2020-2025)
Table 11. Global Human Vaccination Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Human Vaccination Market Share by Region (2026-2031)
Table 13. Human Vaccination Market Trends
Table 14. Human Vaccination Market Drivers
Table 15. Human Vaccination Market Challenges
Table 16. Human Vaccination Market Restraints
Table 17. Global Human Vaccination Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Human Vaccination Market Share by Players (2020-2025)
Table 19. Global Top Human Vaccination Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Vaccination as of 2024)
Table 20. Ranking of Global Top Human Vaccination Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Human Vaccination Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Human Vaccination, Headquarters and Area Served
Table 23. Global Key Players of Human Vaccination, Product and Application
Table 24. Global Key Players of Human Vaccination, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Human Vaccination Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Human Vaccination Revenue Market Share by Type (2020-2025)
Table 28. Global Human Vaccination Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Human Vaccination Revenue Market Share by Type (2026-2031)
Table 30. Global Human Vaccination Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Human Vaccination Revenue Market Share by Application (2020-2025)
Table 32. Global Human Vaccination Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Human Vaccination Revenue Market Share by Application (2026-2031)
Table 34. North America Human Vaccination Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Human Vaccination Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Human Vaccination Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Human Vaccination Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Human Vaccination Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Human Vaccination Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Human Vaccination Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Human Vaccination Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Human Vaccination Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Human Vaccination Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Human Vaccination Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Human Vaccination Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Human Vaccination Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Human Vaccination Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Human Vaccination Market Size by Country (2026-2031) & (US$ Million)
Table 49. GSK Company Details
Table 50. GSK Business Overview
Table 51. GSK Human Vaccination Product
Table 52. GSK Revenue in Human Vaccination Business (2020-2025) & (US$ Million)
Table 53. GSK Recent Development
Table 54. Merck Company Details
Table 55. Merck Business Overview
Table 56. Merck Human Vaccination Product
Table 57. Merck Revenue in Human Vaccination Business (2020-2025) & (US$ Million)
Table 58. Merck Recent Development
Table 59. Sanofi Company Details
Table 60. Sanofi Business Overview
Table 61. Sanofi Human Vaccination Product
Table 62. Sanofi Revenue in Human Vaccination Business (2020-2025) & (US$ Million)
Table 63. Sanofi Recent Development
Table 64. Sinovac Company Details
Table 65. Sinovac Business Overview
Table 66. Sinovac Human Vaccination Product
Table 67. Sinovac Revenue in Human Vaccination Business (2020-2025) & (US$ Million)
Table 68. Sinovac Recent Development
Table 69. Zhejiang Pukang Company Details
Table 70. Zhejiang Pukang Business Overview
Table 71. Zhejiang Pukang Human Vaccination Product
Table 72. Zhejiang Pukang Revenue in Human Vaccination Business (2020-2025) & (US$ Million)
Table 73. Zhejiang Pukang Recent Development
Table 74. Changchun Institute of Biological Company Details
Table 75. Changchun Institute of Biological Business Overview
Table 76. Changchun Institute of Biological Human Vaccination Product
Table 77. Changchun Institute of Biological Revenue in Human Vaccination Business (2020-2025) & (US$ Million)
Table 78. Changchun Institute of Biological Recent Development
Table 79. KM Biologics Company Details
Table 80. KM Biologics Business Overview
Table 81. KM Biologics Human Vaccination Product
Table 82. KM Biologics Revenue in Human Vaccination Business (2020-2025) & (US$ Million)
Table 83. KM Biologics Recent Development
Table 84. IMBCAMS Company Details
Table 85. IMBCAMS Business Overview
Table 86. IMBCAMS Human Vaccination Product
Table 87. IMBCAMS Revenue in Human Vaccination Business (2020-2025) & (US$ Million)
Table 88. IMBCAMS Recent Development
Table 89. Convac Company Details
Table 90. Convac Business Overview
Table 91. Convac Human Vaccination Product
Table 92. Convac Revenue in Human Vaccination Business (2020-2025) & (US$ Million)
Table 93. Convac Recent Development
Table 94. NCPC Company Details
Table 95. NCPC Business Overview
Table 96. NCPC Human Vaccination Product
Table 97. NCPC Revenue in Human Vaccination Business (2020-2025) & (US$ Million)
Table 98. NCPC Recent Development
Table 99. Bio Kangtai Company Details
Table 100. Bio Kangtai Business Overview
Table 101. Bio Kangtai Human Vaccination Product
Table 102. Bio Kangtai Revenue in Human Vaccination Business (2020-2025) & (US$ Million)
Table 103. Bio Kangtai Recent Development
Table 104. Dynavax Company Details
Table 105. Dynavax Business Overview
Table 106. Dynavax Human Vaccination Product
Table 107. Dynavax Revenue in Human Vaccination Business (2020-2025) & (US$ Million)
Table 108. Dynavax Recent Development
Table 109. Hissen Company Details
Table 110. Hissen Business Overview
Table 111. Hissen Human Vaccination Product
Table 112. Hissen Revenue in Human Vaccination Business (2020-2025) & (US$ Million)
Table 113. Hissen Recent Development
Table 114. KM Biologics Company Details
Table 115. KM Biologics Business Overview
Table 116. KM Biologics Human Vaccination Product
Table 117. KM Biologics Revenue in Human Vaccination Business (2020-2025) & (US$ Million)
Table 118. KM Biologics Recent Development
Table 119. LG Life Sciences Company Details
Table 120. LG Life Sciences Business Overview
Table 121. LG Life Sciences Human Vaccination Product
Table 122. LG Life Sciences Revenue in Human Vaccination Business (2020-2025) & (US$ Million)
Table 123. LG Life Sciences Recent Development
Table 124. Serum Institute Company Details
Table 125. Serum Institute Business Overview
Table 126. Serum Institute Human Vaccination Product
Table 127. Serum Institute Revenue in Human Vaccination Business (2020-2025) & (US$ Million)
Table 128. Serum Institute Recent Development
Table 129. Pfizer Company Details
Table 130. Pfizer Business Overview
Table 131. Pfizer Human Vaccination Product
Table 132. Pfizer Revenue in Human Vaccination Business (2020-2025) & (US$ Million)
Table 133. Pfizer Recent Development
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
Table 137. Authors List of This Report
List of Figures
Figure 1. Human Vaccination Picture
Figure 2. Global Human Vaccination Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Human Vaccination Market Share by Type: 2024 VS 2031
Figure 4. Inactivated Vaccine Features
Figure 5. Live-attenuated Vaccine Features
Figure 6. mRNA Vaccine Features
Figure 7. Conjugate Vaccine Features
Figure 8. Other Features
Figure 9. Global Human Vaccination Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Human Vaccination Market Share by Application: 2024 VS 2031
Figure 11. Government Institution Case Studies
Figure 12. Private Sector Case Studies
Figure 13. Other Case Studies
Figure 14. Human Vaccination Report Years Considered
Figure 15. Global Human Vaccination Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Human Vaccination Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Human Vaccination Market Share by Region: 2024 VS 2031
Figure 18. Global Human Vaccination Market Share by Players in 2024
Figure 19. Global Top Human Vaccination Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Vaccination as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Human Vaccination Revenue in 2024
Figure 21. North America Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Human Vaccination Market Share by Country (2020-2031)
Figure 23. United States Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Human Vaccination Market Share by Country (2020-2031)
Figure 27. Germany Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Human Vaccination Market Share by Region (2020-2031)
Figure 35. China Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Human Vaccination Market Share by Country (2020-2031)
Figure 43. Mexico Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Human Vaccination Market Share by Country (2020-2031)
Figure 47. Turkey Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. GSK Revenue Growth Rate in Human Vaccination Business (2020-2025)
Figure 51. Merck Revenue Growth Rate in Human Vaccination Business (2020-2025)
Figure 52. Sanofi Revenue Growth Rate in Human Vaccination Business (2020-2025)
Figure 53. Sinovac Revenue Growth Rate in Human Vaccination Business (2020-2025)
Figure 54. Zhejiang Pukang Revenue Growth Rate in Human Vaccination Business (2020-2025)
Figure 55. Changchun Institute of Biological Revenue Growth Rate in Human Vaccination Business (2020-2025)
Figure 56. KM Biologics Revenue Growth Rate in Human Vaccination Business (2020-2025)
Figure 57. IMBCAMS Revenue Growth Rate in Human Vaccination Business (2020-2025)
Figure 58. Convac Revenue Growth Rate in Human Vaccination Business (2020-2025)
Figure 59. NCPC Revenue Growth Rate in Human Vaccination Business (2020-2025)
Figure 60. Bio Kangtai Revenue Growth Rate in Human Vaccination Business (2020-2025)
Figure 61. Dynavax Revenue Growth Rate in Human Vaccination Business (2020-2025)
Figure 62. Hissen Revenue Growth Rate in Human Vaccination Business (2020-2025)
Figure 63. KM Biologics Revenue Growth Rate in Human Vaccination Business (2020-2025)
Figure 64. LG Life Sciences Revenue Growth Rate in Human Vaccination Business (2020-2025)
Figure 65. Serum Institute Revenue Growth Rate in Human Vaccination Business (2020-2025)
Figure 66. Pfizer Revenue Growth Rate in Human Vaccination Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232